Literature DB >> 33530891

Brazilian Adaptation of the Coronavirus Anxiety Scale: A Psychometric Investigation of a Measure of Coronaphobia.

Fernando E Padovan-Neto1, Sherman A Lee2, Rayanne Poletti Guimarães1, Lívea Dornela Godoy1, Hugo Bononi Costa1, Francisco Luiz Silva Zerbini3, Sérgio S Fukusima1.   

Abstract

This study examined the psychometric properties of a Brazilian adapted version of the Coronavirus Anxiety Scale (CAS-BR) in a sample of adults in Brazil. Confirmatory factor analyses demonstrated that the CAS-BR produces a reliable (α = .84), unidimensional construct whose structure was shown to be invariant across gender, race, and age. However, some items of the CAS-BR were stronger indicators of the coronavirus anxiety construct for women and younger adults. Although the CAS-BR demonstrated evidence of discrimination ability for functional impairment (AUC = .77), Youden indexes were low to identify a clinical cut-score. Construct validity was demonstrated with correlations between CAS-BR scores and measures of functional impairment, generalized anxiety, and depression. Exploratory analyses revealed that CAS-BR total scores were higher among women and participants with a history of anxiety disorder. These findings are consistent with previous investigations and support the validity of CAS-BR for measuring coronavirus anxiety with Brazilian adults.

Entities:  

Keywords:  Brazil; COVID-19; anxiety; coronaphobia; coronavirus

Year:  2021        PMID: 33530891     DOI: 10.1177/0030222821991325

Source DB:  PubMed          Journal:  Omega (Westport)        ISSN: 0030-2228


  8 in total

Review 1.  Gender and COVID-19 related fear and anxiety: A meta-analysis.

Authors:  Ahmet Metin; Eyüp Sabır Erbiçer; Sedat Şen; Ali Çetinkaya
Journal:  J Affect Disord       Date:  2022-05-11       Impact factor: 6.533

2.  Global validation of the Coronavirus Anxiety Scale (CAS).

Authors:  Theo Lieven
Journal:  Curr Psychol       Date:  2021-12-02

3.  Measuring anxiety related to COVID-19: Factor analysis and psychometric properties of the Arabic Coronavirus Anxiety Scale.

Authors:  Zahir Vally; Aisha Alowais
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

4.  COVID-19 seroprevalence after the first UK wave of the pandemic and its association with the physical and mental wellbeing of secondary care healthcare workers.

Authors:  Sonika Sethi; Natasha Manuelpillai; Anandadeep Mandal; Olivia Simpson; Hana Morrissey; Patrick Ball; Hayley Sharrod-Cole; Clare Ford; Anna C Whittaker; Mark Drayson; Adam Race; James Bateman; Supratik Basu; James Cotton
Journal:  Brain Behav Immun Health       Date:  2022-08-06

5.  Factorial Validity, Reliability, Measurement Invariance and the Graded Response Model for the COVID-19 Anxiety Scale in a Sample of Ecuadorians.

Authors:  Rodrigo Moreta-Herrera; Tomás Caycho-Rodríguez; Alexandra Salinas; Micaela Jiménez-Borja; Daniel Gavilanes-Gómez; Carlos José Jiménez-Mosquera
Journal:  Omega (Westport)       Date:  2022-07-19

6.  Assessing anxiety during the COVID-19 delta epidemic: Validation of the Chinese coronavirus anxiety scale.

Authors:  Qiaoping Lian; Lu Xia; Daxing Wu
Journal:  Front Psychol       Date:  2022-09-14

7.  The development of coronaphobia scale and psychometric effect among UAE people.

Authors:  Rasha Abdelrahman; Fouad Mohamed Aldawash
Journal:  Heliyon       Date:  2022-10-04

8.  Cross-cultural validation of the new version of the Coronavirus Anxiety Scale in twelve Latin American countries.

Authors:  Tomás Caycho-Rodríguez; Pablo D Valencia; Lindsey W Vilca; Carlos Carbajal-León; Andrea Vivanco-Vidal; Daniela Saroli-Araníbar; Mario Reyes-Bossio; Michel White; Claudio Rojas-Jara; Roberto Polanco-Carrasco; Miguel Gallegos; Mauricio Cervigni; Pablo Martino; Diego Alejandro Palacios; Rodrigo Moreta-Herrera; Antonio Samaniego-Pinho; Marlon Elías Lobos-Rivera; Andrés Buschiazzo Figares; Diana Ximena Puerta-Cortés; Ibraín Enrique Corrales-Reyes; Raymundo Calderón; Bismarck Pinto Tapia; Ilka Franco Ferrari; Carmen Flores-Mendoza
Journal:  Curr Psychol       Date:  2022-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.